J&J/McNeil Done With Post-Recall Personnel Changes – CEO Weldon
Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.
You may also be interested in...
FDA's Sharfstein says agency "could've done better" in asking questions after it was contacted by J&J about problems with Motrin.
Johnson & Johnson consumer products executive Colleen Goggins' pending retirement could signal a larger executive-level overhaul at the firm
Johnson & Johnson expects the resumption of manufacturing the children's OTC drugs the firm's McNeil Consumer Healthcare business recalled this year may be as far off as April 2011